ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander Sells 4,985 Shares

ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) COO Christian B. Voigtlander sold 4,985 shares of the company's stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $128.50, for a total value of $640,572.50. Following the completion of the transaction, the chief operating officer now directly owns 6,088 shares in the company, valued at $782,308. This trade represents a 45.02% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

ICU Medical Stock Down 0.2%

Shares of ICUI stock traded down $0.31 during mid-day trading on Friday, hitting $134.12. The stock had a trading volume of 279,898 shares, compared to its average volume of 278,492. ICU Medical, Inc. has a 12-month low of $105.30 and a 12-month high of $196.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The firm's 50-day moving average is $137.87 and its two-hundred day moving average is $150.95. The firm has a market capitalization of $3.30 billion, a P/E ratio of -29.35 and a beta of 0.87.

ICU Medical (NASDAQ:ICUI - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.49. ICU Medical had a positive return on equity of 5.05% and a negative net margin of 4.74%. The firm had revenue of $599.49 million during the quarter, compared to the consensus estimate of $574.15 million. During the same period in the previous year, the company posted $0.96 earnings per share. The firm's quarterly revenue was up 6.7% on a year-over-year basis. On average, analysts predict that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ICUI has been the subject of a number of recent analyst reports. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. Raymond James decreased their price objective on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a report on Friday, May 9th. KeyCorp dropped their target price on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Finally, Wall Street Zen raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Sunday, May 18th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $192.67.

Institutional Investors Weigh In On ICU Medical

Large investors have recently modified their holdings of the business. Harvest Fund Management Co. Ltd purchased a new position in ICU Medical during the fourth quarter valued at approximately $33,000. Quarry LP lifted its holdings in ICU Medical by 764.3% during the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock worth $38,000 after buying an additional 214 shares during the period. Murphy & Mullick Capital Management Corp bought a new stake in ICU Medical during the 4th quarter valued at $52,000. Venturi Wealth Management LLC boosted its position in ICU Medical by 64.0% during the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after acquiring an additional 206 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its holdings in shares of ICU Medical by 88.8% in the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after acquiring an additional 300 shares during the period. Institutional investors own 96.10% of the company's stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.